6. Glycemic Targets: Standards of Medical Care in Diabetes—2019
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“pharmacotherapy) and in all-cause mortality (13% and 27%, respectively) (22).”
BackgroundIntensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 1×
“If the patient is meeting A1C target, consider one of three strategies (39):”
Background
Cited by
Items 401–500 of 687
Kshanti, I. A., Aji, G., Epriliawati, M., Mokoagow, M. I., Nasarudin, J., Magfira, N., Sari, A. P., Manurung, A., Djojo, A. Y., Wardoyo, E. Y., et al. (2020) · Bali Medical Journal · doi:10.15562/bmj.v9i3.1969 · Cited by 7
The Frequency and Determinants of HbA1c Variability in Type 2 Diabetic Patients
Keskinler, M. V., Takır, M., Çaklılı, Ö. T., & Oğuz, A. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0131 · Cited by 10
Risk for Imbalanced Blood Glucose Pattern: Construct Analysis and Nursing Diagnosis Proposal
Lopes, R. O. P., Santos, J. D. C., de Oliveira, H. C., Campos, J. F., Primo, C. Ç., Lopes, C. T., & Brandão, M. A. G. (2022) · Clinical Nursing Research · doi:10.1177/10547738211073395 · Cited by 7
Mirzababaei, A., Abaj, F., Hajishizari, S., Bahrampour, N., Noori, S., Barekzai, A. M., Hosseininasab, D., Clark, C. C. T., & Mirzaei, K. (2023) · BMC Women s Health · doi:10.1186/s12905-022-02140-y · Cited by 9
Ratzki‐Leewing, A. A., Black, J. E., Ryan, B. L., Zou, G., Klar, N. S., Webster-Bogaert, S., Timcevska, K., & Harris, S. B. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15186 · Cited by 7
Comparative Analysis of Predictive Interstitial Glucose Level Classification Models
Moser, O., Sourij, H., Lobanovs, S., Kistkins, S., Mihailovs, T., Pīrāgs, V., & Bļizņuks, D. (2023) · Sensors · doi:10.3390/s23198269 · Cited by 7
Grady, M., Cameron, H., Phillips, S., Smith, G., & Setford, S. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819873053 · Cited by 7
Martins, C., Saeki, S. L., do Nascimento, M. M., Júnior, F. M. L., Vavruk, A. M., Meireles, C. L., Justino, S. R., Mafra, D., Rabito, E. I., Schieferdecker, M. E. M., et al. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2020-0210 · Cited by 8
Abdissa, D., Sorsa, R., Gerbi, A., Hamba, N., & Banjaw, Z. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08460 · Cited by 7
Niwaha, A. J., Rodgers, L. R., Carr, A. L. J., Balungi, P., Mwebaze, R. M., Hattersley, A. T., Shields, B. M., Nyirenda, M., & Jones, A. G. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002714 · Cited by 7
Pickett, B., Shin, T. R., & Norton, M. C. (2022) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2022.100211 · Cited by 7
Islam, N., Reynier, P., Douros, A., Yu, O. H. Y., & Filion, K. B. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15000 · Cited by 8
Wang, S., Wen, J., Miao, D., Sun, Z., Li, D., & Pan, E. (2023) · BMC Public Health · doi:10.1186/s12889-022-14856-5 · Cited by 8
Digital Diabetes Care System Observations from a Pilot Evaluation Study in Vietnam
Khanh, T. Q., Hao, P. N., Roitman, E., Raz, I., Marganitt, B., & Cahn, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030937 · Cited by 7
The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Kushner, P. R., & Kruger, D. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0093 · Cited by 7
Kaufman, C. S., Bai, S. X., Eickmeyer, S. M., & Billinger, S. A. (2020) · Brain and Behavior · doi:10.1002/brb3.1990 · Cited by 7
Bille, N., Byberg, S., Gishoma, C., Kristensen, K. B., & Christensen, D. L. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108929 · Cited by 7
Boucher, E., Moskowitz, J. T., Kackloudis, G. M., Stafford, J. L., Kwok, I., & Parks, A. C. (2020) · JMIR Research Protocols · doi:10.2196/18578 · Cited by 6
Glycemic control and its factor in type 2 diabetic patients in Jakarta
Maifitrianti, M., Wulandari, N., Haro, M., Lestari, S. F., & Fitriani, A. (2020) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2020.9.3.198 · Cited by 6
Khodabandehloo, P., Fakembe, P., Senga, J., Shulman, R., Lipscombe, L. L., Witteman, H. O., Banerjee, A., Presseau, J., Nakhla, M., Dogba, M. J., et al. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16426 · Cited by 8
“12 Despite the advantages and cost-effectiveness of diabetes technologies, structural inequities (e.g., subjective prescribing criteria used by providers, provider bias, stigma, mistrust of the healthcare system due to historical and present day racism, non-inclusive language practices, negative…”
Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
Weiss, T., Iglay, K., Gulati, T., Rajpathak, S., Yang, L., & Blonde, L. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002127 · Cited by 6
de Portu, S., Vorrink, L., Ré, R., Shin, J., Castañeda, J., Habteab, A., & Cohen, O. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-050635 · Cited by 7
Setford, S. J., Phillips, S., Cameron, H., & Grady, M. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231158663 · Cited by 6
“23 The resultant linear regression relationships within each glucose range and at low, nominal, and high P o 2 are shown in Table 2 and Figure 2.”
Taleb, N., Gingras, V., Cheng, R., Parent, V., Messier, V., Bovan, D., Shohoudi, A., Brazeau, A., & RABASA-LHORET, R. P. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1186680 · Cited by 6
Zafar, A. S., Albakr, A. I., Shahid, R., Al-Khamis, F. A., Alabdali, M. M., Aljaafari, D., Nazish, S., Alshamrani, F., Shariff, E., Zeeshan, M. A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1249535 · Cited by 6
Le, T., Thanh, K. M., Tran, T. V., Nguyen, D., Nguyen, L., Pham, D., Dam, L. T. P., Hoang, M. Q., & Huynh, Q. T. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s439800 · Cited by 6
Ahmad, S. Z., Ivers, N. M., Zenlea, I. S., Parsons, J. A., Shah, B. R., Mukerji, G., Punthakee, Z., & Shulman, R. M. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00563-2 · Cited by 8
“Compared to adults, they are at a high risk of dropping out of medical care, having acute diabetes complications, and of suboptimal glycemic management which confers an increased risk of chronic diabetes complications [19–22].”
BackgroundMathieu, C., Weisnagel, S. J., Stella, P., Bruhwyler, J., & Alexandre, K. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00749-1 · Cited by 6
Trabecular bone score, a new bone quality index, is associated with severe periodontitis
Niramitchainon, C., Mongkornkarn, S., Sritara, C., Lertpimonchai, A., & Udomsak, A. (2020) · Journal of Periodontology · doi:10.1002/jper.19-0580 · Cited by 6
Maarouf, O. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-83082-3_6 · Cited by 6
Klaric, K., Parai, J. L., Kepron, C., Walker, A. E., & Milroy, C. M. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207998 · Cited by 6
Lin, Y. H., Shi, X., Huang, L., Chen, A., & Zhu, H. (2023) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580231201022 · Cited by 8
“42,43 Second, multicomponent exercise interventions, including aerobic activity and resistance training, have proven to be the best strategies for reducing the risk of frailty and seem to be the most effective strategies for improving balance, gait, and strength, as well as preventing older…”
BackgroundEsposito, K., Longo, M., Maiorino, M. I., Petrizzo, M., Gicchino, M., Bellastella, G., & Giugliano, D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107787 · Cited by 7
Koga, M., Inada, S., Shibata, M., Ijima, H., Jinnouchi, H., Ono, Y., Iwasaka, T., Tokuhiro, S., Matsumura, Y., Matsui, H., et al. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.08.004 · Cited by 6
Gibb, F. W., Jennings, P. L., Leelarathna, L., & Wilmot, E. G. (2020) · British Journal of Diabetes · doi:10.15277/bjd.2020.240 · Cited by 6
Fazioli, K., Rind, D. M., Guzauskas, G. F., Hansen, R. N., & Pearson, S. D. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1072 · Cited by 7
THERAPEUTIC TOY IN PRIMARY CARE: CONTRIBUTIONS FOR THE SYSTEMATIZATION OF NURSING CARE
Pedrinho, L. R., Shibukawa, B. M. C., Rissi, G. P., Uema, R. T. B., Merino, M. D. F. G. L., & Higarashi, I. H. (2021) · Texto & Contexto - Enfermagem · doi:10.1590/1980-265x-tce-2020-0616 · Cited by 6
Patient-Centered Medicine and Self-Care of Patients with Type 2 Diabetes: A Cross-Sectional Study
Sousa, S., Pereira, A. M., & Santiago, L. M. (2023) · Acta Médica Portuguesa · doi:10.20344/amp.18584 · Cited by 6
Nanotechnology: Antidiabetics, Antioxidant and Anti-inflammatory
Samrat, K., Murthy, T. P. K., Divyashri, G., Krishna, R. H., & Chandraprabha, M. N. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_8 · Cited by 6
Kataoka, Y., Hosoda, K., Makino, H., Matsubara, M., Matsuo, M., Ohata, Y., Koezuka, R., Tamanaha, T., Tomita, T., Honda-Kohmo, K., et al. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.09.02 · Cited by 6
Micronutrient status in patients with diabetic foot ulcers: A cross-sectional study in Saudi Arabia
Ababneh, M., Ayed, M. Y. A., Robert, A. A., Amer, M. G., Rashidi, R. A. A., Mansour, F. A., Saeed, A. H. A., & Dawish, M. A. A. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1109_23 · Cited by 5
“[12] ] This study indicated that patients having undergone amputation had a significant association with vitamin B12 ( P = 0.029) levels.”
ResultInfluentialRisk of senescence, polypharmacy, and their outcomes in elderly cardiovascular disease patients
Cebe, T., & Kızılyel, F. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.02.011 · Cited by 6
Impact of Initial eGlycemic Management System Dosing Strategy on Time to Target Blood Glucose Range
Emamdjomeh, A. S., Warren, J. N., Harper, C. L., & Olin, J. L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821992352 · Cited by 5
Overt hypogonadism is a cardiovascular risk factor in type 2 diabetic males: An observational study
Oğuz, A., Şahin, M., Ülgen, C., Uyan, M., & Gül, K. (2021) · Andrologia · doi:10.1111/and.14271 · Cited by 5
Bernal, I. R. A., Miranda-Félix, P. E., & Ortiz-Félix, R. E. (2023) · Revista Ciencias de la Salud · doi:10.12804/revistas.urosario.edu.co/revsalud/a.11674 · Cited by 8
Roberts, G., Chang, L., Park, J. M., & Thynne, T. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110955 · Cited by 5
Implementation of a Teleophthalmology Screening Program for Diabetic Retinopathy in New York City
Capellàn, P., Dillon, A. B., Rodriguez, G., Chua, J., Mahrous, M. A., Kovacs, K. D., Tassel, S. H. V., D’Amico, D. J., Kiss, S., & Orlin, A. (2023) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264231208253 · Cited by 5
Mela, D. J., Alssema, M., Hiemstra, H., Hoogenraad, A.-R., & Kadam, T. (2024) · Nutrients · doi:10.3390/nu16142177 · Cited by 5
“The key treatment target for the management of diabetes is the improvement of glycemic control, which includes not only fasting glucose levels but also postprandial glucose (PPG) responses [1,2].”
BackgroundImagining a better future for all people with type 1 diabetes mellitus
Korsgren, O., Skyler, J. S., Skog, O., Sundberg, F., Forsander, G., & Ludvigsson, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0257-8 · Cited by 5
Outcomes of type A intramural hematoma: Influence of diabetes mellitus
Chen, Q., Jiang, D., Kuang, F., Yang, F., & Shan, Z. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14812 · Cited by 5
Layne, J. E., Huyett, L. M., & Ly, T. T. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819868698 · Cited by 5
Insulin glargine/lixisenatide in type 2 diabetes: a profile of its use
Deeks, E. D. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00670-4 · Cited by 5
Diabetes in the Workplace: the Hazards of Hypoglycemia
Gerbo, R., Jin, C. F., & Clark, K. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1234-2 · Cited by 5
Diabetes-Related Health Care Utilization and Dietary Intake Among Food Pantry Clients
Bomberg, E. M., Rosenmoss, S., Smith, M. C., Waxman, E., & Seligman, H. K. (2019) · Health Equity · doi:10.1089/heq.2019.0102 · Cited by 6
Caswell, M., Brown, D., Frank, J., Wallace, J. F., & Pardo, S. A. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1734919 · Cited by 5
Park, J., Han, J., Chang, M., Ki, Y., Kang, J., Yang, H., Cho, H., Park, K. W., Kang, H., Koo, B., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082464 · Cited by 5
Guide on diabetes and COVID-19 for healthcare professionals in Bangladesh
Bhowmik, B., Ahmed, T., Afsana, F., Qureshi, N., Siddiquee, T., Pathan, F., Amin, F., Moreira, N. C. D. V., Samad, M., Ashrafuzzaman, S., et al. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_51_20 · Cited by 5
Hidalgo, M. A. R., Cirelli, T., da Silva, B. R., Nicchio, I. G., Nepomuceno, R., Orrico, S. R. P., Cirelli, J. A., Theodoro, L. H., Barros, S. P., & Scarel‐Caminaga, R. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06172-9 · Cited by 5
Bock, J. M., Hughes, W. E., Ueda, K., Feider, A. J., Hanada, S., & Casey, D. P. (2021) · Physiological Reports · doi:10.14814/phy2.14764 · Cited by 6
“Indeed, every 1% increase in HbA1c is associated with a commensurate 17% rise in CVD- related complications (Andersson et al., 2012).”
BackgroundRezaei, S., Taheri, A., Taheri, S., Kasirzadeh, S., Fatemi, B., & Sorato, M. M. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2078700 · Cited by 5
Alzahrani, A. M., BinDajam, O. S., AlGhamdi, S. A., AlQarni, S. S., & Farahat, F. M. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2152_21 · Cited by 5
Obesity, Diabetes Mellitus, and Metabolic Syndrome: Review in the Era of COVID-19
Abiri, B., Ahmadi, A. R., Hejazi, M., & Amini, S. (2022) · Clinical Nutrition Research · doi:10.7762/cnr.2022.11.4.331 · Cited by 9
Melaku, T., Chelkeba, L., Mekonnen, Z., & Kumela, K. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s266105 · Cited by 4
Silva, C. E. C., Sarinho, B. B., Bonafé, M., Lima, T. D. M., Rotta, I., Mendes, S. J., Aguiar, P. M., & Visacri, M. B. (2025) · Pharmacy · doi:10.3390/pharmacy13050113 · Cited by 4
“[59,60].”
RSSDI guidelines for management of type 2 diabetes mellitus in older adults
Jagadeesha, A., Viswanathan, V., Agarwal, S., Maheshwari, A., Virmani, A. K., Nagendra, L., Amarnath, A., Chawla, M. S., Jethwani, P., Parikh, R. M., et al. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01613-8 · Cited by 4
Hevesi, J. I. (2024) · Belügyi Szemle · doi:10.38146/bsz.2024.1.5 · Cited by 4
“A TBR tartományt pedig a 3,0 mmol/l érték osztja ketté, ez alatt megjelennek a hipog - likémia neurológiai tünetei, fokozottabb a kockázata a súlyos hipoglikémiá-nak és a halálozásnak (Agiostratidou et al., 2017; International Hypoglyaemia Study Group, 2019; American Diabetes Association, 2019).”
Current situation analysis of diabetic home care patients
Sertbaş, M. (2019) · Northern Clinics of Istanbul · doi:10.14744/nci.2019.59751 · Cited by 4
Boehme, C., Domig, L., Komarek, S., Toell, T., Mayer‐Suess, L., Dejakum, B., Krebs, S., Pechlaner, R., Bernegger, A., Mueller, C., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02785-5 · Cited by 5
Alsharif, A. A., Wong, I. C. K., Ma, T., Lau, W. C. Y., Alhamed, M., Alwafi, H. H., & Wei, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1177636 · Cited by 4
Pros and cons of continous glucose monitoring
Ciechański, M., Witkowska, E., Ostańska, A., Szafran, A., Wiśniewska, K., Piasek, L., Godek, G., Więcław, K., Stańko, K., & Terelak, W. (2023) · Journal of Medical Science · doi:10.20883/medical.e873 · Cited by 4
Impact of socio-economic status on Diabetes Mellitus knowledge and hemoglobin A1c control
Alvi, M. M., Jabeen, S., Zahid, F., Jabeen, A., & Raheem, A. M. B. (2023) · Khyber Medical University Journal · doi:10.35845/kmuj.2023.22983 · Cited by 4
Evaluation of four disease management programs: evidence from blue cross blue shield of Louisiana
Liu, M., Yuan, X., Ouyang, J., Chaisson, J., Bergeron, T., Cantrell, D., Washington, V., Zhang, Y., & Nigam, S. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2020.1722677 · Cited by 5
Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
Shin, J., Kim, H., Kim, C., Kim, C., & Choi, W.-S. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.19.0161 · Cited by 4
A prática de atividade física em pessoas com Diabetes Mellitus tipo 2: estudo transversal
Costa, B. Y., Chaváglia, S. R. R., Ohl, R. I. B., Gamba, M. A., & Meneguci, J. (2020) · Revista Família Ciclos de Vida e Saúde no Contexto Social · doi:10.18554/refacs.v8i3.3905 · Cited by 7
Winter, W. E., Pittman, D. L., Devaraj, S., Li, D., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00008-x · Cited by 4
Kollipara, U., Bernuy, M. C. C. R., Putra, J., Burks, J., Meyer, A., Ferguson, S., Nelson, C., Mutz, J., Mirfakhraee, S., Bajaj, P., et al. (2020) · Clinical Diabetes · doi:10.2337/cd20-0048 · Cited by 5
“The American Diabetes Association recommends A1C testing quarterly in patients whose therapy has changed orwho are notmeeting glycemic goals and at least twice yearly in those who are meeting treatment goals (5).”
BackgroundHypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study
Alão, S., Conceição, J., Dores, J. M., Santos, L. D. C., Araújo, F., de Pape, E. A., Reis, M., Chipepo, Á., Nascimento, E., Baptista, A., et al. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00114-3 · Cited by 4
Ok, E., Kocatepe, V., & Ünver, V. (2021) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/9651 · Cited by 4
Booklet handout to improve glycemic control in type-2-DM patients and comparison with other models
Viviandhari, D., Wulandari, N., & Rahmi, N. (2021) · Pharmaciana · doi:10.12928/pharmaciana.v11i1.17511 · Cited by 4
“Medication adherence in diabetes mellitus is related to better glycemic control, better control of risk factors, lower risk of hospitalization, lower health care cost, and lower risk of mortality (Care, 2019; Kirkman et al., 2015).”
BackgroundMethodBiagi, L., Bertachi, A. H., Giménez, M., Conget, I., Bondía, J., Fernández, J. A. M., & Vehí, J. (2021) · Sensors · doi:10.3390/s21113593 · Cited by 5
Yoshino, K., Hirota, Y., Ogawa, W., Sugawara, K., Kawaguchi, A., Yoshino, H., Ishibashi, M., Yoshino, G., & Koga, M. (2021) · Diabetology International · doi:10.1007/s13340-021-00529-y · Cited by 4
Value of HbA1c in Obese Women with Gestational Diabetes
Oben, A. G., Jauk, V. C., Battarbee, A. N., Longo, S. A., Szychowski, J. M., Tita, A., & Harper, L. M. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1740060 · Cited by 5
Johnston, P. (2022) · British Journal of Nursing · doi:10.12968/bjon.2022.31.1.34 · Cited by 5
Cavallari, G., & Mancini, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061521 · Cited by 6
Kim, K., & Jang, S. (2022) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002445 · Cited by 3
Weir, M. R. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12929 · Cited by 4
Lima, R. A. D., Fernandes, D. R., Garcia, R. A. C., Carvalho, L. A. D. R., Silveira, R. C. D. C. P., & Teixeira, C. R. D. S. (2023) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.6655.4088 · Cited by 5
Clinical Impact of Glucose Levels on Patient Outcome after Transcatheter Aortic Valve Replacement
Khadija, H. A., Alnees, M., Gandelman, G., Awwad, M., Schiller, T., Hamdan, Y., Ayyad, O., Kirzhner, A., Sella, G., Kashquosh, Y., et al. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25336 · Cited by 3
Zou, J., Chen, X., Yu, H., Chen, Y., He, K.-Y., Ruan, D., Zhu, J., Chen, Q., Zhang, J.-H., Zhang, L., et al. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12914 · Cited by 3
Al-Shamsi, S., Govender, R. D., & Soteriades, E. S. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-032654 · Cited by 4
Sakyi, S. A., Opoku, S., Senu, E., Korsah, E. E., Effah, A., Baidoo, B. T., Ansah, E. A., Frimpong, E., Naturinda, E., Kodzo, K. E., et al. (2023) · Public Health Challenges · doi:10.1002/puh2.130 · Cited by 3
“All questions were based on previous validated questions [19] with modifications and the standards of medical care in diabetes by the American Diabetes Association [20].”
Liang, R., Shaker, E., Zhao, M., King, G. E., & Moalli, P. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.02.282 · Cited by 4
Updates and advances in technology for diabetes self-management
Bzowyckyj, A. S. (2019) · Pharmacy Today · doi:10.1016/j.ptdy.2019.04.024 · Cited by 3
Abusamaan, M. S., Klonoff, D. C., & Mathioudakis, N. N. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883332 · Cited by 3
Compliance of checking HbA1c in a tertiary care hospital of Pakistan
Aziz, A., & Ali, S. A. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.1.2814 · Cited by 3
Alchujyan, N., Hovhannisyan, M., Movsesyan, N., Melkonyan, A., Shaboyan, V., Aghajanova, E., Minasyan, G. H., & Kevorkian, G. A. (2021) · Endocrine Research · doi:10.1080/07435800.2021.1920608 · Cited by 3
The Integrated Management of Hypertension in General Hospitals and Community Hospitals
Xie, K., Gao, X., Bao, L., Shan, Y., Shi, H., & Li, Y. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s306735 · Cited by 3
Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease
Swanner, A. A., Hawley, C. E., Li, K., Triantafylidis, L. K., Li, J., & Paik, J. M. (2022) · Clinical Diabetes · doi:10.2337/cd21-0078 · Cited by 3
Iuliano, S., Greco, E. A., Mirabelli, M., CHIEFARI, E. D., Caroleo, P., Puccio, L., Giuliano, S., FOTI, D. P., Brunetti, A., & Aversa, A. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03691-0 · Cited by 3
Paranjpe, R., Johnson, M. L., Chen, H., Birtcher, K. K., Serna, O., Mohan, A., & Abughosh, S. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2705 · Cited by 4
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-12-07
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S61-S70
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4250208868
- Cited by
- 655
- References
- 59
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 35 · 2023: 57 · 2022: 85 · 2021: 117 · 2020: 202 · 2019: 112
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- glycemic targets, glycemic control, diabetes management, clinical guidelines, quality of care, treatment goals
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Societies, Medical, United States, Practice Guidelines as Topic, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.